The complex population of microbes in the human gastrointestinal (GI) tract interacts with
itself and with the host, exerting a deep influence on health and disease development. The …

As Helicobacter pylori management has become more challenging and less efficient over
the last decade, the interest in innovative interventions is growing by the day. Probiotic co …

In the human body, each microbial habitat exhibits a different microbial population pattern,
and these distinctive microflorae are highly related to the development of diseases. The …

Helicobacter pylori (H. pylori) is a gram-negative bacterium that infects approximately 4.4
billion individuals worldwide. Although the majority of infected individuals remain …

Chronic Helicobacter pylori infection is a critical risk factor for gastric cancer (GC). However,
only 1–3% of people with H. pylori develop GC. In gastric carcinogenesis, non-H. pylori …

The microbiome has been hypothesized to play a role in cancer development. Because of
the diversity of published data, an overview of available epidemiologic evidence linking the …

Helicobacter pylori (Hp) is a prevalent organism infecting almost half the global population. It
is a significant concern, given its associated risk of gastric cancer, which is the third leading …

Helicobacter pylori (H. pylori) is generally regarded as a human pathogen and a class 1
carcinogen, etiologically related to gastric and duodenal ulcers, gastric cancer, and mucosa …

The combination of vonoprazan (VPZ) and amoxicillin (VA therapy) has been shown to
achieve acceptable eradication rates for Helicobacter pylori (H. pylori). Herein, our aim was …

Helicobacter pylori infection is a prevalent infectious disease, associated with many gastric
diseases, including gastritis, gastric ulcer, and gastric cancer. To reveal the characteristics of …